143 related articles for article (PubMed ID: 6744246)
21. P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats.
Diwan BA; Rice JM; Nims RW; Lubet RA; Hu H; Ward JM
Cancer Res; 1988 May; 48(9):2492-7. PubMed ID: 3356011
[TBL] [Abstract][Full Text] [Related]
22. Dose-response relationship of diethylnitrosamine-initiated tumors in neonatal balb/c mice: effect of phenobarbital promotion.
Klaunig JE; Pereira MA; Ruch RJ; Weghorst CM
Toxicol Pathol; 1988; 16(3):381-5. PubMed ID: 3194660
[TBL] [Abstract][Full Text] [Related]
23. Butylated hydroxytoluene lacks the activity of phenobarbital in enhancing diethylnitrosamine-induced mouse liver carcinogenesis.
Tokumo K; Iatropoulos MJ; Williams GM
Cancer Lett; 1991 Sep; 59(3):193-9. PubMed ID: 1913615
[TBL] [Abstract][Full Text] [Related]
24. Promotion of hepatocellular foci and adenomas by di(2-ethylhexyl) phthalate and phenobarbital in C3H/HeNCr mice following exposure to N-nitrosodiethylamine at 15 days of age.
Weghorst CM; Devor DE; Henneman JR; Ward JM
Exp Toxicol Pathol; 1994 Feb; 45(7):423-31. PubMed ID: 8167465
[TBL] [Abstract][Full Text] [Related]
25. The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital.
Goldsworthy TL; Pitot HC
Carcinogenesis; 1985 Sep; 6(9):1261-9. PubMed ID: 2863007
[TBL] [Abstract][Full Text] [Related]
26. Chemopreventive effects of melatonin on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats.
Rahman KM; Sugie S; Watanabe T; Tanaka T; Mori H
Nutr Cancer; 2003; 47(2):148-55. PubMed ID: 15087267
[TBL] [Abstract][Full Text] [Related]
27. Cell proliferation and regulation of negative growth factors in mouse liver foci.
Moser GJ; Wolf DC; Harden R; Standeven AM; Mills J; Jirtle RL; Goldsworthy TL
Carcinogenesis; 1996 Sep; 17(9):1835-40. PubMed ID: 8824503
[TBL] [Abstract][Full Text] [Related]
28. Superoxide deficiency attenuates promotion of hepatocarcinogenesis by cytotoxicity in NADPH oxidase knockout mice.
Parzefall W; Freiler C; Lorenz O; Koudelka H; Riegler T; Nejabat M; Kainzbauer E; Grasl-Kraupp B; Schulte-Hermann R
Arch Toxicol; 2015 Aug; 89(8):1383-93. PubMed ID: 25182417
[TBL] [Abstract][Full Text] [Related]
29. A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model.
Sun H; Yu L; Wei H; Liu G
J Biomed Biotechnol; 2012; 2012():584728. PubMed ID: 22500097
[TBL] [Abstract][Full Text] [Related]
30. Modifying effects of butylated hydroxyanisole, di(2-ethylhexyl)phthalate or indomethacin on mouse hepatocarcinogenesis initiated by N-nitrosodiethylamine.
Hagiwara A; Diwan BA; Ward JM
Jpn J Cancer Res; 1986 Dec; 77(12):1215-21. PubMed ID: 3102426
[TBL] [Abstract][Full Text] [Related]
31. [Dose-response relationship of promotion by phenobarbital in rat two-stage hepatocarcinogenesis].
Onodera H; Matsushima Y; Uneyama C; Shibutani M; Mitsumori K; Maekawa A; Hayashi Y
Eisei Shikenjo Hokoku; 1991; (109):55-60. PubMed ID: 1364405
[TBL] [Abstract][Full Text] [Related]
32. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis.
Chattopadhyay MB; C B MK; Kanna PS; Ray RS; Roy S; Chatterjee M
J Gastroenterol Hepatol; 2004 Jun; 19(6):683-93. PubMed ID: 15151625
[TBL] [Abstract][Full Text] [Related]
33. Rat hepatocarcinogenesis induced by N-nitrosodiethylamine and N-nitrosomorpholine continuously administered at low doses. From basophilic areas of hepatocytes to hepatocellular tumors.
Cortinovis C; Klimek F; Nogueira E
Am J Pathol; 1991 Nov; 139(5):1157-71. PubMed ID: 1951631
[TBL] [Abstract][Full Text] [Related]
34. The inhibitory effect of sodium selenite on N-nitrosodiethylamine-induced and phenobarbital promoted liver tumourigenesis in rats based on the modulation of polyamine levels.
Thirunavukkarasu C; Premkumar K; Jagadeeswaran R; Sakthisekaran D
Mol Cell Biochem; 2005 Dec; 280(1-2):165-72. PubMed ID: 16311919
[TBL] [Abstract][Full Text] [Related]
35. The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration.
Goldsworthy T; Campbell HA; Pitot HC
Carcinogenesis; 1984 Jan; 5(1):67-71. PubMed ID: 6140089
[TBL] [Abstract][Full Text] [Related]
36. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
LeBoeuf RA; Laishes BA; Hoekstra WG
Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004
[TBL] [Abstract][Full Text] [Related]
37. Enhancing effect of malachite green on the development of hepatic pre-neoplastic lesions induced by N-nitrosodiethylamine in rats.
Fernandes C; Lalitha VS; Rao KV
Carcinogenesis; 1991 May; 12(5):839-45. PubMed ID: 1674233
[TBL] [Abstract][Full Text] [Related]
38. Gender-dependent differences in hepatic tumor promotion in diethylnitrosamine initiated infant B6C3F1 mice by alpha-hexachlorocyclohexane.
Siglin JC; Weghorst CM; Rodwell DE; Klaunig JE
J Toxicol Environ Health; 1995 Feb; 44(2):235-45. PubMed ID: 7531777
[TBL] [Abstract][Full Text] [Related]
39. Quantitative stereologic study of the effects of varying the time between initiation and promotion on four histochemical markers in rat liver during hepatocarcinogenesis.
Xu YH; Maronpot R; Pitot HC
Carcinogenesis; 1990 Feb; 11(2):267-72. PubMed ID: 1967985
[TBL] [Abstract][Full Text] [Related]
40. Suppressive effect of enzymatically modified isoquercitrin on phenobarbital-induced liver tumor promotion in rats.
Morita R; Shimamoto K; Ishii Y; Kuwata K; Ogawa B; Imaoka M; Hayashi SM; Suzuki K; Shibutani M; Mitsumori K
Arch Toxicol; 2011 Nov; 85(11):1475-84. PubMed ID: 21445586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
